Arcadia Biosciences, Inc.
NASDAQRKDA short interest drops 25% in a week to 0.53% of float, lowest level since late April.
Snapshot as of 23 Jun 2026
Arcadia Biosciences heads into its May 15 earnings report as one of the more technically distressed micro-caps on Nasdaq, with the stock down nearly 50% year-to-date and trading at $1.07. The price tells the clearest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RKDA — free to start on ORTEX.
Sign up for free →Open RKDA on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live RKDA data →